BIO
NYSE
$301.95
Bio-Rad Laboratories Inc - Class A (BIO)
Bio-Rad Laboratories, Inc. is an American developer and manufacturer of specialized technological products for the life science research and clinical diagnostics markets.
This company is also listed under the following ticker: BIO-B.
Website: https://www.bio-rad.comSector:
Healthcare
Industry:
Medical Devices
Buy
Target: $297 (-1.64%)
Market Cap
$7.97B
Free Cash Flow Yield
4.48%
Beta (5Y)
0.89
Price Chart
Valuation
Market Cap$7.97B
Forward P/E34.36
PEG1.19
P/S3.06
P/B1.17
Profitability
Total Revenue (TTM)$2.59B
Gross Profit (TTM)$1.35B
EBITDA-$560M
Profit Margin-89%
Operating Margin5.8%
EPS-$18.29
Financial Health
Debt-to-Equity11.7%
Free Cash Flow Yield4.48%
Growth & Risk
Revenue 5Y CAGR-0.83%
FCF 5Y CAGR-7.56%
Beta (5Y)0.89
Sharpe Ratio0.57